Astera Labs (NASDAQ:ALAB) Shares Up 3.2% – Should You Buy?

Shares of Astera Labs, Inc. (NASDAQ:ALAB) were up 3.2% on Thursday . The company traded as high as $283.17 and last traded at $282.82. Approximately 2,785,628 shares changed hands during trading, a decline of 48% from the average daily volume of 5,307,264 shares. The stock had previously closed at $274.13.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Demand for Astera Labs’ Scorpio, Aries and Taurus connectivity platforms is supporting expectations for strong third-quarter growth and strengthening the company’s position in AI data-center infrastructure. ALAB Stock Down 24% in a Month: Should Investors Buy the Dip or Wait?
• Positive Sentiment: The company’s latest quarterly results exceeded expectations, with earnings per share of $0.80 versus the $0.69 consensus estimate and revenue of $392.4 million versus $360.85 million. Revenue rose 104.5% year over year, while management issued third-quarter EPS guidance of $1.16 to $1.21.
• Positive Sentiment: Analyst sentiment remains generally constructive: Astera Labs has a “Moderate Buy” consensus rating and an average price target of $348.33, above recent trading levels. Northland upgraded the shares to outperform with a $350 target, while Morgan Stanley maintained an overweight rating with a $335 target.
• Neutral Sentiment: Despite the favorable growth outlook, ALAB has declined 13.9% since its latest earnings report and 24% over the past month, reflecting elevated valuation expectations and uncertainty about the pace of future growth. The stock’s high beta and elevated earnings multiple may contribute to volatility. Why Is Astera Labs Down Since Its Earnings Report?
• Negative Sentiment: Director Manuel Alba sold 183,000 shares for approximately $51.3 million, reducing his holdings by 41.9%. Director Stefan Dyckerhoff separately sold 12,499 shares worth about $3.4 million. The transactions were made under pre-arranged Rule 10b5-1 plans, which reduces their value as a discretionary bearish signal, but the sales may still weigh on investor sentiment and add near-term supply. SEC Insider Trading Filing

Analyst Ratings Changes

Several research firms recently issued reports on ALAB. UBS Group reissued a “neutral” rating and issued a $425.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Astera Labs in a research report on Tuesday, August 18th. Barclays increased their price objective on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research note on Monday, July 20th. Susquehanna raised their price objective on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research report on Friday, July 31st. Finally, Evercore restated an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a research note on Tuesday, May 19th. One investment analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $348.33.

Astera Labs Price Performance

The stock has a market cap of $53.85 billion, a PE ratio of 153.66 and a beta of 3.77. The stock has a 50-day moving average price of $330.74 and a two-hundred day moving average price of $254.36.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same quarter last year, the business earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities research analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Insider Buying and Selling

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the completion of the sale, the director directly owned 253,863 shares in the company, valued at approximately $71,114,642.19. The trade was a 41.89% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan Dyckerhoff sold 3,505 shares of the stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $274.96, for a total value of $963,734.80. Following the transaction, the director directly owned 50,456 shares of the company’s stock, valued at $13,873,381.76. The trade was a 6.50% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 592,244 shares of company stock worth $209,729,973 in the last quarter. 10.40% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. California State Teachers Retirement System raised its position in shares of Astera Labs by 49,273.2% in the second quarter. California State Teachers Retirement System now owns 100,158,544 shares of the company’s stock valued at $48,378,580,000 after buying an additional 99,955,684 shares during the last quarter. BlackRock Inc. acquired a new position in Astera Labs during the second quarter worth about $6,609,581,000. Bank of America Corp DE acquired a new position in Astera Labs during the second quarter worth about $1,061,791,000. Atreides Management LP boosted its position in Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after acquiring an additional 1,754,593 shares during the last quarter. Finally, Amundi grew its stake in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after acquiring an additional 1,319,643 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.